Overview Efficacy of Aprepitant (Emend®) in Children Status: Completed Trial end date: 2017-06-29 Target enrollment: Participant gender: Summary The purpose of this study is to find out whether or not adding aprepitant(Emend®) to the standard therapy will help children who receive chemotherapy to have less nausea and vomiting. Phase: Phase 3 Details Lead Sponsor: University of OklahomaTreatments: AntiemeticsAprepitantBB 1101DexamethasoneDexamethasone 21-phosphateDexamethasone acetateFosaprepitantOndansetron